Produktname:Methyl 4-((dimethoxyphosphoryl)methyl)benzoate
IUPAC Name:methyl 4-[(dimethoxyphosphoryl)methyl]benzoate
- CAS:78022-19-2
- Molekulare Formel:C11H15O5P
- Reinheit:95%+
- Katalognummer:CM544351
- Molekulargewicht:258.21
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:78022-19-2
- Molekulare Formel:C11H15O5P
- Schmelzpunkt:-
- SMILES-Code:O=C(OC)C1=CC=C(CP(OC)(OC)=O)C=C1
- Dichte:
- Katalognummer:CM544351
- Molekulargewicht:258.21
- Siedepunkt:
- Mdl-Nr.:MFCD20488953
- Lagerung:
Column Infos
- Palovarotene
- A breakthrough treatment raises hopes for rare bone disease. Palovarotene (Sohonos) has been recently approved by the FDA as a retinoid indicated for the reduction in volume of new heterotopic ossification in adults and pediatric patients aged 8 years and older for females and 10 years and older for males with fibrodysplasia ossificans progressiva (FOP). FOP is an ultra-rare progressive genetic disease effecting one in a million individuals. This first and only treatment is able to effectively reduce the formation of new abnormal bone in soft and connective tissues.